Loading
Below, week by week, is what OnCo's record of Anaplastic thyroid cancer says about the first two months: the order is typical, the timing is yours to ask about. Anaplastic thyroid cancer is the rare, fast-growing form that presents as a rapidly enlarging neck mass threatening the airway. Few patients lived more than a few months; combining BRAF-targeted drugs, immunotherapy, surgery and radiotherapy has lifted survival for the first time. Sections appear only where the record has something to say. Orientation, not medical advice.
Staging tests establish exactly what and where the cancer is. Everything else follows from the answers.
Core biopsy with rapid BRAF testing, airway assessment, staging CT and PET; multidisciplinary planning within days.
Ask which of these were tested and what the results were; see the report reader for what each value means.
These specialties appear in the standard of care for this cancer. In most centres they meet weekly as a tumour board to agree each plan; you can ask when yours was discussed and what was decided.
A second opinion from a centre that treats many similar cases is normal, not rude; the standard of care tells you what to compare it against.
Each row is a setting from the standard of care, in the order it usually arises. Not all will apply to you; your stage and biomarkers decide which do. The guideline grade, where recorded, says how strong the evidence is.
Surgery followed by chemoradiation (paclitaxel- or doxorubicin-based).
Chemoradiation or immunotherapy in trials; lenvatinib in some countries; palliative radiotherapy and airway support.
Dabrafenib plus trametinib, with pembrolizumab in many centres; neoadjuvant use to make tumours resectable, then surgery and radiotherapy.
Generated from this cancer's standard of care, biomarkers and open problems. Take the group that matches where you are. To tick, add your own and print, open the one-page appointment sheet.
Much of what helps in the first weeks is free if you know to ask: testing, helplines, rides and lodging, second opinions, trial travel.